Katatonie

Peter Bräunig; Stephanie Krüger

doi:10.1055/s-2004-834747

Psychiatrische Praxis, Inhaltsverzeichnis

Psychiatr Prax 2005; 32: 7-24
DOI: 10.1055/s-2004-834747

Originalarbeit

Katatonie

Eine ÜbersichtCatatoniaAn OverviewPeter Bräunig¹ , Stephanie Krüger²

¹Klinikum Chemnitz gGmbH, Klinik für Psychiatrie, Verhaltensmedizin und Psychosomatik
²Technische Universität Dresden, Universitätsklinikum Carl-Gustav-Carus, Klinik für Psychiatrie und Psychotherapie

Abstract

Zusammenfassung

Katatonien sind durch psychische, motorische, verhaltensbezogene und autonome Symptome charakterisierte neuropsychiatrische Syndrome. Sie treten in klinischen Inanspruchnahmepopulationen bei bis zu 18 % der akut erkrankten Patienten auf, am häufigsten bei affektiven und psychotischen Störungen aber auch bei dissoziativen Störungen, pervasiven Entwicklungsstörungen, mentaler Retardierung und bei organischen psychischen Störungen. Katatone Symptome sind eindrucksvolle Krankheitszeichen, die klinisch und psychopathometrisch reliabel und valide diagnostiziert und effektiv behandelt werden können. Trotz ihrer Charakteristik werden sie jedoch oft nicht erkannt und bleiben bei therapeutischen Entscheidungen entsprechend unberücksichtigt. Mit der in diesem Beitrag gegebenen Übersicht zu ausgewählten, die Katatonie betreffenden Fragestellungen wird das Ziel verfolgt, zu einer verbesserten Diagnostik und Therapie katatoner Symptome und Zustandbilder beizutragen.

Abstract

Catatonia is a neuropsychiatric syndrome charaterized by mental, motor and behavioral symptoms. It occurs in up to 18 % of acute admissions and is most frequently associated with affective and psychotic disorders. It is also seen in dissociative disorders, pervasive developmental disorders, mental retardation and organic psychiatric disorders. Catatonic syndromes are impressive states that can be reliably and validly diagnosed both clinically and with psychometric measurements and they can be treated effectively. Despite this, they are often not recognized in clinical practice, are not part of the therapeutic strategy and thus remain untreated. The following article is intended to give a review of the most pertinent questions related to the diagnosis and treatment of catatonia in order to improve clinicians' ability to recognize and treat catatonic symptoms and syndromes adequately.

Volltext

Referenzen

Literatur

1 Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien. In: Aschaffenburg G (Hrsg) Handbuch der Psychiatrie. Spezieller Teil. 4. Abteilung 1. Hälfte. Leipzig. Wien; Deuticke 1911
2 Kleist K. Untersuchungen zur Kenntnis der psychomotorischen Bewegungsstörungen bei Geisteskranken. Leipzig; Klinkhardt 1908
3 Kleist K. Die klinische Stellung der Motilitaetspsychosen. Allg Z Psychiatr. 1912; 69 109-113
4 Kleist K. Über Zykloide, paranoide und epileptische Psychosen und Ueber die Frage der Degenerationspsychosen. Schweiz Arch Neurol Psychiatr. 1928; 23 1-35
5 Kleist K. Die Katatonien. Nervenarzt. 1943; 16 1-10
6 Kraepelin E. Psychiatrie. Ein Lehrbuch fuer Studirende und Aerzte. 2 Baende. Leipzig; Barth 1899
7 Kraepelin E. Psychiatrie. Ein Lehrbuch fuer Studirende und Aerzte. Leipzig; Barth 1913
8 Lange J. Katatonische Erscheinungen im Rahmen manisch-depressiver Erkrankungen. Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie. Berlin, Germany; Springer 1922
9 Leonhard K. Die defektschizophrenen Krankheitsbilder. Leipzig; Thieme 1936
10 Leonhard K. Aufteilung der endogenen Psychosen (1957). 6. Aufl. Berlin; Akademie-Verlag 1986
11 Wetzel H, Heuser I, Benkert O. Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiat. 1988; 6 394-395
12 Bräunig P. Extrapyramidalmotorische Störungen bei Schizophrenien bereits in der präneuroleptischen Ära beobachtet. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptikainduzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 18-22
13 Caligiuri M P, Lohr J B, Jeste D V. Parkinsonism in neuroleptic-naïve schizophrenic patients. American Journal of Psychiatry. 1993; 150 1343-1348
14 Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane J M, Alvir J, Liebermann J A. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. American Journal of Psychiatry. 1995; 152 1724-1729
15 Fenton W S. Prevalence of spontaneaous dyskinesia in schizophrenia. J Clin Psychiatry. 2000; 61 (4) 10-14
16 McCreadie R G, Ohaeri J U. Movement disorder in never and minimally treated Nigerian schizophrenic patients. British Journal of Psychiatry. 1994; 164 184-189
17 McCreadie R G, Thara R, Kamath S, Padmrathy R, Latha S, Nathrubootham N, Menon M S. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry. 1996; 168 221-226
18 Owens D GC, Johnstone E C, Frith C D. Spontaneous involuntary disorders of movement. Their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neurolepties. Arch Gen Psychiatry. 1982; 39 452-481
19 Puri B K, Barnes T R, Chapmn M J, Hutton S B, Joyce E M. Spontaneous dyskinesia in first episode schizophrenia. J Neurol Neurosurg Psychiatry. 1999; 66 (1) 76-78
20 Abrams R, Taylor M A. Unipolar mania: a preliminary report. Arch Gen Psychiatry. 1974; 30 441-443
21 Abrams R, Taylor M A. Catatonia: a prospective clinical study. Arch Gen Psychiatry. 1796; 33 579-581
22 Abrams R, Taylor M A. Catatonia: prediction of response to somatic treatments. Am J Psychiatry. 1977; 23 78-80
23 Abrams R, Taylor M A, Coleman-Stolurow K A. Catatonia and mania: patterns of cerebral dysfunction. Biol Psychiatry. 1979; 14 111-117
24 Bräunig P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry. 1998; 39 35-46
25 Fein S, McGrath M G. Problems in diagnosing bipolar disorder in catatonic patients. J Clin Psychiatry. 1990; 51 203-205
26 Fink M. Delirious mania. Bipolar Disorders. 1999; 1 54-60
27 Hoch A A. Benign Stupors: A Study of a New Manic-depressive Reaction Type. New York; Cambridge University Press 1921
28 Kirby G H. The catatonic syndrome and its relation to manic-depressive insanity. J Nerv Ment Disord. 1913; 40 694-704
29 Krüger S, Bräunig P. Catatonia in affective disorder: new findings and a review of the literature. CNS Spectr. 2000b; 5 48-53
30 Krüger S, Cooke R G, Spegg C C, Bräunig P. Relevance of the catatonic syndrome to the mixed manic episode. Journal of Affective Disorders . 2003b; 7 279-285
31 Morrison J R. Catatonia: retarded and excited types. Arch Gen Psychiatry. 1973; 28 (1) 39-41
32 Ries R K. DSM-III implications of the diagnoses of catatonia and bipolar disorder. Am J Psychiatry. 1985; 142 1471-1474
33 Taylor M A, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry. 1973; 29 (4) 520-522
34 Taylor M A, Abrams R. Catatonia. Prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatr. 1977; 34 (10) 1223-1225
35 Taylor M A, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003; 160 (7) 1233-1241
36 Caroff S N, Mann S C, Francis A, Fricchione G L. Catatonie: From Psychopathology to Neurobiology. Washington DC, London; England American Psychiatric Publishing Inc 2004: 121-127
37 Fink M, Taylor M A. Catatonia: A clinician's guide to diagnosis and treatment. Cambridge UK; Cambridge University Press 2003
38 Gelenberg A J. The catatonic syndrome. Lancet. 1976; 1 1339-1341
39 Taylor M A. Catatonia. A review of the behavioral neurologic syndrome. Neuropsychiat Neuropsychol Behar Neurol. 1990; 3 48-72
40 Costa E, Davis J M, Dong E, Grayson D R, Guidotti A, Tranolizzo L, Veldic M. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol. 2004; 16 (1 - 2) 1-23
41 Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry. 1997; 62 404-406
42 Bostroem A. Striäre Störungen. In: Bunke O (Hrsg) Handbuch der Geisteskrankheiten. 2. Band. Berlin; Springer 1928
43 Bräunig P. Diagnostische Erfassung und Bewertung motorischer Störungen bei chronischen Schizophrenien - das katatone Dilemma. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptikainduzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 2-11
44 Bräunig P, Krueger S, Shugar G. et al . The catatonia rating scale I: development, reliability, and use. Compr Psychiatry. 2000; 41 147-158
45 Fink M, Taylor M A. Catatonia: a separate category in DSM-IV?. Integr Psychiatry. 1991; 7 2-10
46 Kleist K. Gehirnpathologie. Leipzig; Barth 1934
47 Northoff G. Katatonie. Einführung in die Phänomenologie, Klinik und Pathophysiologie eines psychomotorischen Syndroms. Stuttgart; Enke 1997
48 Ungvari G S, Carroll B T. Nosology. In: Caroff SN, Mann, SC, Francis A, Fricchione GL Catatonia, From Psychopathology to Neurobiology. Washington DC, London, England; American Psychiatric Publishing Inc 2004: 33-43
49 Wernicke C. Grundriß der Psychiatrie in klinischen Vorlesungen. Leipzig; Thieme 1900
50 Kahlbaum K L. Klinische Abhandlungen ueber psychische Krankheiten. 1. Heft: Die Katatonie oder das Spannungsirresein. Berlin; Hirschwald 1874
51 Kretzschmar E. Die Willensapparate des Hysterischen. Z ges Neurol Psychiat. 1920; 17 251-280
52 Bräunig P (Hrsg). Differenzierung katatoner und neuroleptikainduzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995
53 Bräunig P (Hrsg). Motorische Störungen bei schizophrenen Psychosen. Stuttgart, New York; Schattauer 1999
54 Bräunig P, Krüger S. History. In: Caroff SN, Mann SC, Francis A, Fricchione GL Catatonia. From Psychopathology to Neurobiology. Washington DC; American Psychiatric Publishing Inc 2004: 1-14
55 Bräunig P, Krüger S. Karl Ludwig Kahlbaum (1828 - 1899) - ein Protagonist der modernen Psychiatrie. Psychiat Prax. 2000; 27 112-118
56 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington DC; American Psychiatric Press 1996
57 World Health Organization .The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions an Diagnostic Guidelines. Geneva; WHO 1992
58 Krüger S, Baby M, Höffler J, Bräunig P. Factor analysis of the Catatonia Rating Scale and catatonic symptom distribution across four diagnostic groups. Comprehensive Psychiatry. 2003a; 44 (6) 472-482
59 Thakur A, Jagadheesan K, Dutta S, Sinha V K. Incidence of catatonia in children and adolescents in a paediatric psychiatric clinic. Aust N Z J Psychiatry. 2003; 37 (2) 200-203
60 Joyston-Bechal M P. The clinical features and outcome of stupor. Br J Psychiatry. 1996; 112 967-981
61 Morrison J R. Catatonia: prediction of outcome. Compr Psychiatry. 1974 a; 15 317-324
62 Taylor M A. Clinical Examination. In: Caroff SN, Mann SC, Francis A, Fricchione GL Catatonia, From Psychopathology to Neurobiology. Washington DC, London, England; American Psychiatric Publishing Inc 2004: 45-52
63 Wilmanns K. Zur Differentialdiagnostik funktioneller Psychosen. Centralbl Nervenheilk Psychiatr. 1907; 31 569-573
64 Starkstein S E, Petracca G, Chemerinski E, Merello M, Migliorelli R. Catatonia in depression: prevalence, clinical correlates and validation of a scale. J Neurol Neurosurg Psychiatry. 1996; 60 (3) 326-332
65 Schneider K. Klinische Psychopathologie. Stuttgart, New York; Thieme 1987
66 Höffler J, Bräunig P. Abnahme der Häufigkeit katatoner Schizophrenien im Epochenvergleich. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Stuttgart; Thieme 1995: 32-35
67 Mundt C, Lange H. Die Psychopathologie der Schizophrenien. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Ströngren E (Hrsg) Schizophrenie. Psychiatrie der Gegenwart, 4. Bd. Berlin, Heidelberg, New York, Tokyo; Springer 1987
68 Guggenheim F G, Babigian H M. Catatonic schizophrenia: epidemiology and clinical course. J Nerv Ment Dis. 1974; 158 291-305
69 Bräunig P. Zur Frage der „Katatonia alternans” und zur Differentialtypologie psychomotorischer Psychosen. Fortschr Neurol Psychiat. 1991; 59 92-96
70 Mahendra B. Where have all the catatonics gone?. Psychol Med. 1981; 11 669-671
71 Höffler J, Bräunig P, Börner J, Krüger S. Untersuchung zum Einfluss veränderter diagnostischer Kriterien auf die Häufigkeit der Diagnose „katatone Schizophrenie”. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995a: 43-46
72 Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearence of catatonic schizophrenia?. Comprehensive Psychiatry. 2002; 43 167-174
73 Ungvari G S, Leung S K, Ny F S, Chenung H K, Leung T. Schizophrenia with prominent catatonic features („catatonic schizophrenia”). I Demographic and clinical correlates in the chronic phase. Prog. Neuropsychopharmacol Biol Psychiatry. 2005; 29 (1) 27-38
74 Astrup C. The Chronic Schizophrenias. Oslo; Foto-Trykk, Trogstad 1979
75 Bleuler M. Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Stuttgart; Thieme 1972
76 Bräunig P, Börner I, Krüger S. Diagnostische Merkmale katatoner Schizophrenien. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 36-42
77 Brüne M, Bräunig P. Stabilität und Variabilität katatoner Symptome im Krankheitslängsschnitt. Videografische Dokumentation einer katatonen Schizophrenie. Nervenarzt. 1999; 70 26-30
78 Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997; 27 83-92
79 Ciompi L, Müller C. Lebensweg und Alter der Schizoprenen. Berlin, Heidelberg, New York; Springer 1976
80 Francis A, Divadeena M K, Bush G, Petrides G. Consistency of symptoms in recurrent catatonia. Compr Psychiatry. 1997; 38 58-60
81 Höffler J, Bräunig P, Börner J. et al .Factor-analysis of catatonic schizophrenia, in Syllabus and Proceedings Summary, American Psychiatric Association Annual Meeting, Toronto, Ontario, Canada, May 30-June 4, 1998. Washington DC; American Psychiatric Association 1998: 204-205
82 Höffler J, Bräunig P. Katatone Symptome bei chronischen Schizophrenien: Eine Symptomfindungsstudie. In: Bräunig R (Hrsg) Motorische Störungen bei schizophrenen Psychosen. Stuttgart, New York; Schattauer 1999: 8-16
83 Krüger S, Bräunig P, Höffler J, Shugar G, Börner I, Langkrär J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatr Clin Neurosci. 2000a; 1 16-24
84 Rogers D. Motor disorders of severe psychiatric illness: a conflict of pardigens. Brit J Psychiatry. 1985; 147 221-232
85 Rogers D. Motor disorder in psychiatry. Towards neurological psychiatry. Chichester; Wiley 1992
86 Ungvari G S, Chow L Y, Leung C M. et al . Rating chronic catatonia: discrepancy between cross-sectional and longitudinal assessment. Revista de Psiquiatria Clinica. 1999; 26 56-61
87 Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996a; Vol-Nr.? 129-136
88 Fink M, Bush G, Francis A. Catatonia: a treatable disorder, occasionally recognized. Directions in Psychiatry. 1993; 13 1-7
89 Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996b; 93 137-143
90 Pfuhlmann B, Stöber G. The importance of a differentiated psychopathology of catatonia. Acta Psychiatrica Scand. 1997; 95 357 (Letter 7. the editor)
91 Bräunig P, Krüger S, Höffler J. Verstärkung katatoner Symptome unter Neuroleptikatherapie. Nervenarzt. 1995; 66 379-382
92 Brenner I, Rheuban W J. The catatonic dilemma. American Journal of Psychiatry. 1978; 125 1242-1243
93 Gelenberg A J, Mandel M R. Catatonic reactions to high - potency neuroleptic drugs. Arch Gen Psychiatry. 1977; 34 947-950
94 McKenna P J, Lund C E, Mortimer A M. Motor, volitional and behavioural disorders in schizophrenia, 2: the „conflict of paradigms” hypothesis. Br J Psychiatry. 1991; 158 328-336
95 Sachdev P. Akathisia and Restless legs. Cambridge; Cambridge University Press 1995
96 Huang T L, Ree S C, Huang Y C, Liu H Y, Yang Y Y. Catatonic features: differential diagnosis and treatment at an emergency unit. Psychiatry Clin Neurosci. 1999; 53 (1) 63-66
97 Rosebush P I, Hildebrand A M, Furlong B G, Mazurek M F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry. 1990; 51 357-362
98 Northoff G, Koch A, Wenke J. et al . Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999; 14 404-416
99 Lund C E, Mortimer A M, Rogers D, Mckenna P J. Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. British Journal of Psychiatry. 1991; 158 323-327
100 Peralta V, Cuesta M J, Serrano J F. et al . The Kahlbaum syndrome: a study of its clinical ralidity, nosologic status and relationship with schizophrenia and mood disorder. Compr Psychiatry. 1997; 38 61-67
101 Peralta V, Cuesta M J. Motor features in psychotic disorders, II: development of diagnostic criteria for catatonia. Schizophr Res. 2001b; 47 117-126
102 Ghaziuddin M, Quinlan P, Ghaziuddin N. Catatonia in autism: a distinct subtype?. J Intellect Disabil Res. 2005; 49 (Pt 1) 102-105
103 Hare D J, Malone C. Catatonia and autistic spectrum disorders. Autism. 2004; 8 (2) 183-195
104 Seidel M. Katatoniforme Symptome bei geistig Behinderten und das Katatonieproblem - eine wissenschaftliche Perspektive zum aktuellen Thema Doppeldiagnose. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 64-73
105 Neumaerker K-J. Diagnostik, Therapie und Verlauf katatoner Schizophrenien im Kindesalter. In: Braeunig P (Hrsg) Differenzierung katatoner und neuroleptikainduzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 47-63
106 Trott G E. Die katatone Schizophrenie im Kindes- und Jugendalter. In: Bräunig P (Hrsg) Motorische Störungen bei schizophrenen Psychosen. Stuttgart, New York; Schattauer 1999: 198-210
107 Carroll B T, Goforth H W. Medical Catatonia. In: Caroff SN, Mann SC, Francis A, Fricchione GL Catatonia, From Psychopathology to Neurobiology. Washington, DC, London, England; American Psychiatric Publishing Inc 2004: 121-127
108 Lee J, Schwartz D L, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry. 2000; 12 89-96
109 Bonner C, Kent G. Overlapping symptoms in catatonic excitement and manic excitement. Am J Psychiatry. 1936; 92 1311-1322
110 Klaesi J. Ueber die Bedeutung und Entstehung der Stereotypien. Berlin; Karger 1922
111 Huber G. Pneumencephalographische und psychopathologische Bilder bei endogenen Psychosen. Berlin, Göttingen, Heidelberg; Springer 1957
112 Huber G. Chronische Schizophrenie. Synopsis klinischer und neuroradiologischer Untersuchungen an defektschizophrenen Anstaltspatienten. Heidelberg, Frankfurt; Hüthig 1961
113 Huber G, Gross G, Schüttler R. Schizophrenie. Eine verlaufs- und sozialpsychiatrische Langzeitstudie. Berlin, Heidelberg, New York, Tokyo; Springer 1979
114 Mayer-Gross W. Die Klinik. In: Bumke O (Hrsg) Handbuch der Geisteskrankheiten, Band 9. Die Schizophrenie. Berlin; Springer 1932
115 Spoerri T. Motorische Schablonen und Steretypien bei schizophrenen Endzustaenden. Psychiatrie-Neurologie. 1967; 153 81-127
116 Ungvari G S. The Wernicke-Kleist-Leonhard school of psychiatry. Biol Psychiatry. 1993; 34 749-752
117 Ungvari G S, Leung C M, Wong M K, Lau J. Benzodiazepines in the treatment of the catatonic syndrome. Acta Psychiatr Scand. 1994; 4 258-288
118 Ungvari G S, Chiu H FK, Chow L Y. et al . Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology (Berl). 1999; 142 393-398
119 Ungvari G S, Chiu H F, Chow L Y, Lau B S, Tang W K. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999; 142 393-398
120 Ungvari G S, Kau L S, Wai-Kwong T. et al . The pharmacological treatment of catatonia: an overview. Eur Arch Psychatriy Clin Neurosci. 2001; 251 (suppl 1) 131-134
121 Levy W O, Nunez C Y. Use of ziprasidone to treat bipolar-associated catatonia. Bipolar Disord. 2004; 6 (2) 166-167
122 Berrios G E. Stupor: a conceptual history. Psychol Med. 1981; 11 677-688
123 Wald D, Lerner J. Lithium in the treatment of periodic catatonia: a case report. Am J Psychiatry. 1978; 135 (6) 751-752
124 Fish F J. The influence of the tranquillisers on the Leonhard schizophrenic syndromes. Encephale. 1964; 53 245-249
125 Fricchione G L, Cassem N H, Hooberman D. et al . Intravenous lorazepam in neuroleptic induced catatonia. J Clin Psychopharmacol. 1983; 3 338-342
126 Fricchione G. Catatonia: a new indication for benzodiazepines?. Biol Psychiatry. 1989; 8 761-765
127 Gaind G S, Rosebush P I, Mazurek M F. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry. 1994; 55 20-23
128 Hawkins J M, Archer K J, Strakowski S M. et al . Somatic treatment of catatonia. Int J Psychiatry Med. 1995; 25 354-369
129 McEvoy J P, Lohr J B. Diazepam for catatonia. Am J Psychiatry. 1984; 141 284-285
130 Menza M A, Harris D. Benzodiazepines and catatonia: an overview. Biol Psychiatry. 1989; 26 842-846
131 Panzer M, Tandon R, Greden J F. Benzodiazepines and catatonia. Biol Psychiatry. 1990; 28 178-179
132 Rosebush P I, Hildebrand A M, Mazurek M F. The treatment of catatonia: benzodiazepines or ECT?. Am J Psychiatry. 1992; 49 1279
133 Rosebush P I, Mazurek M. A consideration of the mechanisms by which lorazepam might treat catatonia. J Clin Psychiatry. 1991; 52 187-188
134 Rosebush P l, Mazurek M F. Pharmacotherapy. In: Caroff SN, Mann SC, Francis A, Fricchione GL Catatonia, From Psychopathology to Neurobiology. Washington, DC, London, England; American Psychiatric Publishing Inc 2004: 141-150
135 Rosebush P I, Mazurek M F. Relationship between primary diagnosis and responsiveness to lorazepam in patients presenting to a psychiatry service with catatonia. Ann Neurology. 1994; 36 279-280
136 Vinogradov S, Reiss A L. Use of lorazepam in treatment-resistant catatonia. J Clin Psychopharmacol. 1986; 6 232-235
137 Yassa R, Iskandar H, Lalinec M. et al . Lorazepam as an adjunct in the treatment of catatontic states: an open clinical trial. J Clin Psychopharmacol. 1990; 10 66-68
138 Börner I, Bräunig P. Pharmakotherapie katatoner Schizophrenien. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptika-induzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 93-97
139 Duggal H S. Risperidone treatment of febrile catatonia in first-episode psychosis. Gen Hosp Psychiatry. 2005; 27 (1) 80-81
140 Hesslinger B, Walden J, Norman C. Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry. 2001; 34 (1) 25-26
141 Kane J, Honigfeld G, Singer J. et al . Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry. 1988; 45 789-796
142 Naber D, Holzbach R, Perro C. et al . Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry. 1992; 160 (suppl 17) 54-59
143 Poulsen U J, Noring K, Fog R. et al . Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with for up to 12 years. Acta Psychiatr Scand. 1985; 71 176-185
144 Fink M. Is catatonia a primary indication for ECT?. Convuls Ther. 1990; 6 1-4
145 Finkbeiner T. EKT-Behandlung katatoner Psychosen: Indikation und praktische Durchführung. In: Bräunig P (Hrsg) Differenzierung katatoner und neuroleptikainduzierter Bewegungsstörungen. Stuttgart, New York; Thieme 1995: 98-104
146 Petursson H. Lithium treatment of a patient with periodic catatonia. Acta Psychiatr Scand. 1976; 54 (4) 248-253
147 Albucher R C, DeQuardo J, Tandon R. Treatment of catatonia with an anticholinergic agent. Biol Psychiatry. 1991; 29 513-514
148 Neppe V M. Management of catatonic stupor with L-dopa. Clin Neuropharmacol. 1988; 11 90-91
149 Krüger S, Bräunig P. Intravenous valproic acid in the treatment of severe catatonia. J Neuropsychiatry Clin Neurosci. 2001; 13 (2) 303-304
150 Kritzinger P R, Jordaan G P. Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol. 2001; 4 (3) 251-257
151 Peterson A D, Estroff T W, Sweeney D R. Severe prolonged catatonia with associated flushing reaction responsive lithium carbonate. J Am Acad Child Psychiatry. 1985; 24 (2) 235-237
152 Sugahara Y, Tsukamoto H, Sasaki T. Lithium carbonate in prophylaxis of reappearing catatonic stupor: case report. Psychiatry Clin Neurosci. 2000; 54 (5) 607-609
153 Pataki J, Zervas I M, Jandorf L. Catatonia in a university inpatient service (1985 - 1990). Convuls Ther. 1992; 8 163-173
154 Thomas G CG, Wilson D C. The recognition of pre-schizophrenic states. Virginia Medical Monthly. 1949; 76 405-410
155 Astrup C, Fossum A, Holmboe R. Prognosis in functional psychoses. Springfield; Thomas 1962
156 Carpenter W T, Bartko J J, Carpenter C L. et al . Another view of schizophrenia subtypes. A report from the International Pilot Study of Schizophrenia. Arch Gen Psychiatry. 1976; 33 508-516
157 Manschreck T C, Maher B A, Rucklos M E. et al . Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982; 12 73-84
158 Cernovsky Z Z, Landmark J A, Merskey H. et al . The relationship of catatonia symptoms to symptoms of schizophrenia. Can J Psychiatry. 1998; 43 1031-1035
159 Achté K A. The course of schizophrenia and schizophreniform psychoses. Acta Psychiatr Neurol Scand Suppl. 1961; 155 1-273
160 Hogarty G E, Gross M. Preadmission symptom differences between first-admitted schizophrenics in the predrug and postdrug era. Compr Psychiatry. 1966; 7 134-140
161 Morrison J R. Changes in subtype diagnosis of schizophrenia: 1920 - 1966. Am J Psychiatry. 1974b; 131 674-677
162 Leff J. Psychiatry around the globe: A Transcultural View. New York; Marcel Dekker 1981
163 Templer D I, Veleber D M. The decline of catatonic schizophrenia. Journal of Orthomolecular Psychiatry. 1981; 10 156-158
164 Northoff G, Lins H, Boker H, Danos P, Bogerts B. Therapeutic efficacy of N-methyl D-aspartat antagonist amantadine in febrile catatonia. J Clin Psychopharmacol. 1999; 19 (5) 484-486
165 Francis A, Divadeenam K M, Petrides G. Advances in the diagnosis and treatment of catatonia with lorazepam and ECT. Convuls Ther. 1996; 12 259-261
166 Holtmann M, Meyer A E, Pitzer M, Schmidt M H. Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report. Pharmacopsychiatry. 2003; 36 (6) 317-318
167 Lai J Y, Huang T L. Catatonic features noted in patients with post-partum mental illness. Psychiatry Clin Neurosci. 2004; 58 (2) 157-162
168 Oulis P, Lykonras L, Gournellis R. et al . Psychomotor disturbance in psychiatric inpatients: a clinical study. Psychiatr Belg. 1997; 97 181-191
169 Rommel O, Tegenthoff M, Widdig W, Bräunig P, Malin J P. Organic catatonia following frontal lose injury: response to clozapine. J Neuropsychiatry Clin Neurosci. 1998; 10 (2) 237-238
170 Wlazlo A, Kleszczynski J, Blaszczyk A, Tyfel P, Jakubczyc A, Morasiewicz J. The frequency of diagnosis of catatonic schizophrenia hospitals in Lubliniec (1894 - 1932, 1934 - 1936, 1970 - 1999) and Boleslawiec (1958 - 1999). Pychiatr Pol. 2003; 37 (4) 695-701

Prof. Dr. Peter Bräunig

Klinikum Chemnitz gGmbH · Klinik für Psychiatrie, Verhaltensmedizin und Psychosomatik

Dresdner Straße 178

09131 Chemnitz

eMail: p.braeunig@skc.de